The growth of Point-of-Care (POC) In Vitro Diagnostic (IVD) testing is supported by continual technology improvements and the recognition that rapid test results offer improved patient outcomes and economic benefits. J-Pac Medical’s frangible and burst seal technology offers a sophisticated, cost-effective solution for reliably dispensing unit-of-use reagents precisely to a targeted area in POC medical diagnostic devices. The integration of frangible seal reagent blisters into these technology platforms holds promise for more precise and reproducible results compared to currently accepted testing methods.
J-Pac Medical’s frangible and burst seal technology reduces test complexity by storing and enabling the controlled release of testing reagents, eliminating the need for complex fluid handling. As a result, the device manufacturer is able to better control performance variability, reduce overall manufacturing and disposal costs, and simplify the end-user experience.
Using differential weld strengths designed and engineered to be permanent; break, distort or yield on contact actuation; or fail under a specific pressure, these unit-of-use reagent reservoirs can be customized to interface with a variety of different diagnostic test platforms. The weld strengths are a function of the material properties and applying unique welding processes that are combinations of pressure, temperature and time to meet the seal specification.
Point-of-Care Testing (POCT) platforms utilizing J-Pac Medical seals provide improved patient outcomes with accurate test results that both the patient and clinician can trust, while eliminating the multi-step lab processes where human error and instrument contamination are most likely to occur.